- Home
- » Tags
- » Mocetinostat
Top View
- HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin As A
- MGMT-Activated DUB3 Stabilizes MCL1 and Drives Chemoresistance in Ovarian Cancer
- New and Emerging HDAC Inhibitors for Cancer Treatment
- A Phase 1/2 Study of HDAC Inhibitor, Mocetinostat, In
- Specific Mtor Inhibitors in the Treatment of X-Linked Adrenoleukodystrophy
- Histone Deacetylases
- Phase II Study of Mocetinostat (MGCD0103) in Patients with Relapsed and Refractory Classical Hodgkin Lymphoma
- Histone Deacetylase Inhibition Has Cardiac and Vascular Protective Effects in Rats with Pressure Overload Cardiac Hypertrophy
- Scholar Commons @USF
- Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical
- Role of Histone Deacetylases (Hdacs) in Epilepsy and Epileptogenesis
- Targeted Inhibition of Histone Deacetyltransferases for Pancreatic Cancer Therapy
- Drugs and Epigenetic Molecular Functions. a Pharmacological Data Scientometric Analysis
- A High-Throughput Screening Identifies Histone Deacetylase Inhibitors As
- Histone Deacetylase Inhibitors for Cancer Therapy: an Evolutionarily Ancient Resistance Response May Explain Their Limited Success
- Epigenetic Treatment of Pancreatic Cancer: Is There Gut: First Published As 10.1136/Gutjnl-2016-312539 on 3 November 2016
- Integration of EMT and Cellular Survival Instincts in Reprogramming of Programmed Cell Death to Anastasis
- (12) United States Patent (10) Patent No.: US 9,682,093 B2 Singh (45) Date of Patent: Jun
- (2006.01) Ao, At, Au, Az, Ba, Bb, Bg, Bh, Bn, Br, Bw, By, Bz, 10
- The Role of the Nucleosome Remodeling Factor NURF In
- Activity of Epigenetic Inhibitors Against Plasmodium Falciparum Asexual And
- Tackling Tumor Microenvironment Through Epigenetic Tools to Improve Cancer Immunotherapy Iris Lodewijk1,2†, Sandra P
- Epigenetics in Blood–Brain Barrier Disruption Stephanie A
- Inhibition of Class I Histone Deacetylases 1 and 2 Promotes Urothelial Carcinoma Cell Death by Various Mechanisms Maria Pinkerneil1, Michele J
- Phase II Study of Mocetinostat Administered with Gemcitabine For
- Microbial Short-Chain Fatty Acids Modulate CD8+ T Cell Responses and Improve Adoptive Immunotherapy for Cancer
- Emerging Role of Histone Deacetylase Inhibitors As Anti-Breast-Cancer
- A Novel Metabolism-Based Phenotypic Drug Discovery Platform in Zebrafish Uncovers Hdacs 1 and 3 As a Potential Combined Anti-Sei
- 2011/147588 Al
- Orphan Drug Designations and Approvals List As of 03‐01‐2016 Governs April 1, 2016